Cellular heparan sulfate negatively modulates transforming growth factor-beta1 (TGF-beta1) responsiveness in epithelial cells (Q46955947)

26 December 2017

title

Cellular heparan sulfate negatively modulates transforming growth factor-beta1 (TGF-beta1) responsiveness in epithelial cells (English)

1 reference

26 December 2017

author name string

Chun-Lin Chen

series ordinal

1

1 reference

26 December 2017

Shuan Shian Huang

series ordinal

2

1 reference

26 December 2017

Jung San Huang

series ordinal

3

1 reference

26 December 2017

language of work or name

English

0 references

publication date

21 February 2006

1 reference

26 December 2017

Journal of Biological Chemistry

published in

1 reference

26 December 2017

volume

281

1 reference

26 December 2017

issue

17

1 reference

26 December 2017

page(s)

11506-11514

1 reference

26 December 2017

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

The transforming growth factor-beta family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Receptors for the TGF-β family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Expression of a new type high molecular weight receptor (type V receptor) of transforming growth factor beta in normal and transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Identification of insulin receptor substrate proteins as key molecules for the TbetaR-V/LRP-1-mediated growth inhibitory signaling cascade in epithelial and myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Proteoglycans as modulators of growth factor activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

The low density lipoprotein receptor-related protein complexes with cell surface heparan sulfate proteoglycans to regulate proteoglycan-mediated lipoprotein catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

LRP-1/TbetaR-V mediates TGF-beta1-induced growth inhibition in CHO cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Hyaluronan regulates transforming growth factor-beta1 receptor compartmentalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Transforming growth factor beta activates Smad2 in the absence of receptor endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Autocrine release of TGF-beta by portal fibroblasts regulates cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

TGF-beta control of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Distinct endocytic pathways regulate TGF-β receptor signalling and turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Ligand-dependent and -independent transforming growth factor-beta receptor recycling regulated by clathrin-mediated endocytosis and Rab11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

TGF-beta activation by traction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Making sense of latent TGFbeta activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Role of Ras and Mapks in TGFbeta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Hepatocyte growth factor releases epithelial and endothelial cells from growth arrest induced by transforming growth factor-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

TGF-beta receptor expression and binding in rat mesangial cells: modulation by glucose and cyclic mechanical strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

In vivo interactions of TGF-beta and extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Central role of TGF-beta in the pathogenesis of diabetic nephropathy and macrovascular complications: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

Structural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/angiomodulin that induces cord-like structures to ECV-304 human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512821200

21 January 2018

Identifiers

DOI

10.1074/JBC.M512821200

1 reference

26 December 2017

PubMed ID

16492675

1 reference

26 December 2017